Drapkin Kimberlee C has filed 9 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 13500 shares of LENZ Therapeutics, Inc. ($LENZ) on June 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | LENZ Therapeutics, Inc. | $LENZ | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 4, 2025 | Climb Bio, Inc. | $CLYM | Drapkin Kimberlee C | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 67,475,395 | 9999.99% | 0.06% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Drapkin Kimberlee C | Director | A | Common Stock | 12800 | $0.00 | 12,800.0000 | 60,573,425 | 9999.99% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| March 28, 2025 | Climb Bio, Inc. | $CLYM | Drapkin Kimberlee C | Not found | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 67,475,395 | 9999.99% | 0.12% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| July 28, 2023 | LENZ Therapeutics, Inc. | $LENZ | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |